Share this article on:

Editorial introduction

Section Editor(s): Hegele, Robert A.

Current Opinion in Lipidology: April 2014 - Volume 25 - Issue 2 - p v
doi: 10.1097/MOL.0000000000000065
Editorial introduction

Current Opinion in Lipidology was launched in 1990. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editor for this issue.

Back to Top | Article Outline


Robert A. Hegele

Robert A

Robert A

Rob Hegele is Distinguished University Professor of Medicine and Biochemistry, University of Western Ontario, Canada, and director of the Lipid Genetics Clinic and the London Regional Genomics Centre in London, Ontario, Canada. He received his MD degree from the University of Toronto, Canada in 1981. His specialty training in internal medicine and in endocrinology & metabolism was also in Toronto. His post-doctoral research fellowships were at Rockefeller University, USA, and Howard Hughes Medical Institute, University of Utah, USA. From 1989 to 1997 he was on the Faculty of Medicine at the University of Toronto. In 1997 Dr Hegele joined the Schulich School of Medicine and Dentistry and the Robarts Research Institute at the Western University, in London, Ontario, Canada, where he holds the Jacob J. Wolfe Distinguished Medical Research and the Martha Blackburn Chair in Cardiovascular Research. His lab studies the genetics of lipoprotein metabolism, cardiovascular disease and diabetes mellitus. Solely or through collaborations, his lab was first to describe the molecular genetic basis of 14 human diseases. His lab has also defined much of the genetic basis of such complex traits, including hypertriglyceridemia. He has (co-) authored over 510 peer-reviewed publications and has contributed to national treatment guidelines for dyslipidemia, hypertension and diabetes. He is a member of the American Society of Clinical Investigation and the Canadian Academy of Health Sciences, among several other professional organizations. He serves on editorial boards of the Journal of Lipid Research and several American Heart Association journals. He has trained numerous physicians and graduate students.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins